Infraredx, a Nipro Company, is advancing the diagnosis and management of coronary artery disease by providing cardiologists with the most precise imaging tools required to predict and ultimately prevent heart attacks. Infraredx, a Nipro Company, is dedicated to advancing this important field of research and conducting landmark clinical trials to transform how we view and treat heart disease. For more information about the Makoto™ Imaging System or the OKAY® II Y-Connector please visit www.infraredx.com and connect with Infraredx, a Nipro Company on Twitter and LinkedIn. For more information visit: www.infraredx.com
Stay in touch on social media